111 Inc

Pharmaceutical Retailers

Prices are adjusted according to historical splits.

111 Inc Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$216.70 million
Book Value:
Revenue TTM:
$14.67 billion
Operating Margin TTM:
Gross Profit TTM:
$265.26 million
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

111 Inc had its IPO on 2018-09-12 under the ticker symbol YI.

The company operates in the Healthcare sector and Pharmaceutical Retailers industry. 111 Inc has a staff strength of 1,657 employees.

Stock update

Shares of 111 Inc opened at $2.63 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.52 - $2.63, and closed at $2.59.

This is a -1.53% slip from the previous day's closing price.

A total volume of 30,508 shares were traded at the close of the day’s session.

In the last one week, shares of 111 Inc have slipped by -0.01%.

111 Inc's Key Ratios

111 Inc has a market cap of $216.70 million, indicating a price to book ratio of -0.6883 and a price to sales ratio of 0.0212.

In the last 12-months 111 Inc’s revenue was $14.67 billion with a gross profit of $265.26 million and an EBITDA of $-204615008. The EBITDA ratio measures 111 Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, 111 Inc’s operating margin was -1.72% while its return on assets stood at -5.12% with a return of equity of -37.31%.

In Q2, 111 Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 14.5%.

111 Inc’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-0.48 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into 111 Inc’s profitability.

111 Inc stock is trading at a EV to sales ratio of 0.0175 and a EV to EBITDA ratio of -0.6219. Its price to sales ratio in the trailing 12-months stood at 0.0212.

111 Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$3.05 billion
Total Liabilities
$2.32 billion
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

111 Inc ended 2024 with $3.05 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $3.05 billion while shareholder equity stood at $-446086000.00.

111 Inc ended 2024 with $0 in deferred long-term liabilities, $2.32 billion in other current liabilities, 57000.00 in common stock, $-3515582000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $576.41 million and cash and short-term investments were $699.46 million. The company’s total short-term debt was $309,698,000 while long-term debt stood at $0.

111 Inc’s total current assets stands at $2.83 billion while long-term investments were $2.00 million and short-term investments were $123.05 million. Its net receivables were $515.94 million compared to accounts payable of $1.51 billion and inventory worth $1.39 billion.

In 2024, 111 Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, 111 Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

111 Inc stock is currently trading at $2.59 per share. It touched a 52-week high of $4 and a 52-week low of $4. Analysts tracking the stock have a 12-month average target price of $5.96.

Its 50-day moving average was $2.88 and 200-day moving average was $2.86 The short ratio stood at 1.19 indicating a short percent outstanding of 0%.

Around 1672.3% of the company’s stock are held by insiders while 2802.6% are held by institutions.

Frequently Asked Questions About 111 Inc

The stock symbol (also called stock or share ticker) of 111 Inc is YI

The IPO of 111 Inc took place on 2018-09-12

Similar Industry Stocks (Pharmaceutical Retailers)

Last Price

Most Active

Last Price
Amyris Inc (AMRS)
Humbl Inc (HMBL)

Top Gainers

Last Price
Latch Inc (LTCHW)

Top Losers

Last Price


111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People’s Republic of China. It operates through two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, sexual wellness products, and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. In addition, it offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. The company operates offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. It serves pharmacies, pharmaceutical companies, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People’s Republic of China.


No.295 ZuChongZhi Road, Shanghai, China, 201203